Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Archives of Biochemistry and Biophysics|January 10, 1995
In vitro processing of anthrax toxin protective antigen by recombinant PC1 (SPC3) and bovine intermediate lobe secretory vesicle membranesT C Friedman, V M Gordon, S H Leppla, et al.The Journal of Biological Chemistry|September 5, 1989
Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cellsV M Gordon, W W Young, S M Lechler, et al.Cell Death & Disease|January 18, 2014
Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteinsC Bachran, R Hasikova, C E Leysath, et al.Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysN S Duesbery, J Resau, C P Webb, et al.The Journal of Biological Chemistry|September 10, 1999
Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptorsV M Gordon, K L Nelson, J T Buckley, et al.Vaccine|December 12, 2001
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion proteinO Moriya, M Matsui, M Osorio, et al.The Journal of Biological Chemistry|November 26, 1998
The pore-forming toxin proaerolysin is activated by furinL Abrami, M Fivaz, E Decroly, et al.Nature|November 9, 2001
Crystal structure of the anthrax lethal factorA D Pannifer, T Y Wong, R Schwarzenbacher, et al.Science (New York, N.Y.)|May 23, 1998
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factorN S Duesbery, C P Webb, S H Leppla, et al.Pageof 7